A long-term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization

BMC Cardiovascular Disorders

Volumn 7, Issue , 2007, Pages

  Kamat, Chandrashekhar D ^a   Thorpe, Jessica E ^a   Shenoy, Satyendra S ^a,c   Ceriello, Antonio ^b   Green, Dixy E ^a   Warnke, Linda A ^a   Ihnat, Michael A ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c Piramal Enterprises Limited   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; OXYGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN BNIP3; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; GENE IDENTIFICATION; GENE TARGETING; GENETIC CODE; HEART FAILURE; HUMAN; HUMAN CELL; HYPOXIA; OXYGEN CONCENTRATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UBIQUITINATION; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

AORTA; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GLUCOSE TRANSPORTER TYPE 1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOPRECIPITATION; MEMBRANE PROTEINS; MYOCYTES, SMOOTH MUSCLE; OXYGEN; PROTEIN C INHIBITOR; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846977014     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-7-4     Document Type: Article

References (72)

1. Landmesser U Hornig B Drexler H Endothelial function: A critical determinant in atherosclerosis? Circulation 2004 109 21 Suppl 1 II27-33 15173060
2. Aronson D Rayfield EJ Chesebro JH Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction Ann Intern Med 1997 126 4 296-306 9036802
3. Bugiardini R Manfrini O Pizzi C Fontana F Morgagni G Endothelial function predicts future development of coronary artery disease: A study of women with chest pain and normal coronary angiograms Circulation 2004 109 21 2518-2523 10.1161/01.CIR.0000128208.22378.E3 15136498
4. Britland ST Young RJ Sharma AK Clarke BF Relationship of endoneurial capillary abnormalities to type and severity of diabetic polyneuropathy Diabetes 1990 39 8 909-913 2373263
5. Farhangkhoee H Khan ZA Kaur H Xin X Chen S Chakrabarti S Vascular endothelial dysfunction in diabetic cardiomyopathy: Pathogenesis and potential treatment targets. Pharmacol Ther 2005 16343639
6. Guay AT Relation of endothelial cell function to erectile dysfunction: implications for treatment. Am J Cardiol 2005 96 12B 52M-56M 10.1016/ j.amjcard.2005.10.006 16387568
7. Szocs K Endothelial dysfunction and reactive oxygen species production in ischemia/reperfusion and nitrate tolerance Gen Physiol Biophys 2004 23 3 265-295 15638116
8. Meraji S Jayakody L Senaratne MP Thomson AB Kappagoda T Endothelium-dependent relaxation in aorta of BB rat Diabetes 1987 36 8 978-981 3596063
9. Schmetterer L Findl O Fasching P Ferber W Strenn K Breiteneder H Adam H Eichler HG Wolzt M Nitric oxide and ocular blood flow in patients with IDDM Diabetes 1997 46 4 653-658 9075807
10. Soriano FG Virag L Szabo C Diabetic endothelial dysfunction: Role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation J Mol Med 2001 79 8 437-448 10.1007/s001090100236 11511974
11. Felmeden DC Lip GY Endothelial function and its assessment. Expert Opin Investig Drugs 2005 14 11 1319-1336 10.1517/13543784.14.11.1319 16255673
12. Catrina SB Okamoto K Pereira T Brismar K Poellinger L Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function Diabetes 2004 53 12 3226-3232 15561954
13. Higashi Y Nishioka K Umemura T Chayama K Yoshizumi M Oxidative stress, endothelial function and angiogenesis induced by cell therapy and gene therapy. Curr Pharm Biotechnol 2006 7 2 109-116 10.2174/ 138920106776597658 16724945
14. Dery MA Michaud MD Richard DE Hypoxia-inducible factor 1: Regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol 2005 37 3 535-540 10.1016/j.biocel.2004.08.012 15618010
15. Wang GL Jiang BH Rue EA Semenza GL Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension Proc Natl Acad Sci U S A 1995 92 12 5510-5514 41725 7539918 10.1073/ pnas.92.12.5510
16. Yu F White SB Zhao Q Lee FS HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation Proc Natl Acad Sci U S A 2001 98 17 9630-9635 55503 11504942 10.1073/pnas.181341498
17. Maxwell PH Wiesener MS Chang GW Clifford SC Vaux EC Cockman ME Wykoff CC Pugh CW Maher ER Ratcliffe PJ The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature 1999 399 6733 271-275 10.1038/20459 10353251
18. Hara S Hamada J Kobayashi C Kondo Y Imura N Expression and characterization of hypoxia-inducible factor (HIF)-3alpha in human kidney: Suppression of HIF-mediated gene expression by HIF-3alpha Biochem Biophys Res Commun 2001 287 4 808-813 10.1006/bbrc.2001.5659 11573933
19. Semenza GL Angiogenesis in ischemic and neoplastic disorders Annu Rev Med 2003 54 17-28 10.1146/annurev.med.54.101601.152418 12359828
20. Haddad JJ Olver RE Land SC Antioxidant/pro-oxidant equilibrium regulates HIF-1alpha and NF-kappa B redox sensitivity. Evidence for inhibition by glutathione oxidation in alveolar epithelial cells J Biol Chem 2000 275 28 21130-21139 10.1074/jbc.M000737200 10801793
21. Chandel NS McClintock DS Feliciano CE Wood TM Melendez JA Rodriguez AM Schumacker PT Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: A mechanism of O2 sensing J Biol Chem 2000 275 33 25130-25138 10.1074/ jbc.M001914200 10833514
22. Hagen T Taylor CT Lam F Moncada S Redistribution of intracellular oxygen in hypoxia by nitric oxide: Effect on HIF1alpha Science 2003 302 5652 1975-1978 10.1126/science.1088805 14671307
23. Duyndam MC Hulscher TM Fontijn D Pinedo HM Boven E Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1alpha protein by the oxidative stressor arsenite. J Biol Chem 2001 276 51 48066-48076 11641398
24. Salnikow K Blagosklonny MV Ryan H Johnson R Costa M Carcinogenic nickel induces genes involved with hypoxic stress Cancer Res 2000 60 1 38-41 10646848
25. Hellwig-Burgel T Rutkowski K Metzen E Fandrey J Jelkmann W Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1 Blood 1999 94 5 1561-1567 10477681
26. Jiang BH Jiang G Zheng JZ Lu Z Hunter T Vogt PK Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1 Cell Growth Differ 2001 12 7 363-369 11457733
27. Richard DE Berra E Gothie E Roux D Pouyssegur J p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1 J Biol Chem 1999 274 46 32631-32637 10.1074/jbc.274.46.32631 10551817
28. Roy S Sala R Cagliero E Lorenzi M Overexpression of fibronectin induced by diabetes or high glucose: Phenomenon with a memory Proc Natl Acad Sci U S A 1990 87 1 404-408 53272 2296596 10.1073/pnas.87.1.404
29. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus Jama 2002 287 19 2563-2569 10.1001/jama.287.19.2563 12020338
30. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) study Jama 2003 290 16 2159-2167 10.1001/jama.290.16.2159 14570951
31. Dilsizian V Bateman TM Bergmann SR Des Prez R Magram MY Goodbody AE Babich JW Udelson JE Metabolic imaging with beta-methyl-p-[(123)I]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia. Circulation 2005 112 14 2169-2174 10.1161/ CIRCULATIONAHA.104.530428 16186423
32. Strandberg TE Pyorala K Cook TJ Wilhelmsen L Faergeman O Thorgeirsson G Pedersen TR Kjekshus J Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S). Lancet 2004 364 9436 771-777 10.1016/S0140-6736(04)16936-5 15337403
33. Bosch J Lonn E Pogue J Arnold JM Dagenais GR Yusuf S Long-term effects of ramipril on cardiovascular events and on diabetes: Results of the HOPE study extension. Circulation 2005 112 9 1339-1346 10.1161/ CIRCULATIONAHA.105.548461 16129815
34. Ades EW Candal FJ Swerlick RA George VG Summers S Bosse DC Lawley TJ HMEC-1: Establishment of an immortalized human microvascular endothelial cell line J Invest Dermatol 1992 99 6 683-690 10.1111/ 1523-1747.ep12613748 1361507
35. Wang GL Semenza GL Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia J Biol Chem 1993 268 29 21513-21518 8408001
36. Wang GL Semenza GL Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction Blood 1993 82 12 3610-3615 8260699
37. Bierhaus A Chevion S Chevion M Hofmann M Quehenberger P Illmer T Luther T Berentshtein E Tritschler H Muller M Wahl P Ziegler R Nawroth PP Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells Diabetes 1997 46 9 1481-1490 9287050
38. Barchowsky A Klei LR Dudek EJ Swartz HM James PE Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite Free Radic Biol Med 1999 27 11-12 1405-1412 10.1016/S0891-5849(99)00186-0 10641735
39. Zou MH Klein T Pasquet JP Ullrich V Interleukin 1beta decreases prostacyclin synthase activity in rat mesangial cells via endogenous peroxynitrite formation Biochem J 1998 336 Pt 2 507-512 1219897 9820830
40. Yeo EJ Chun YS Cho YS Kim J Lee JC Kim MS Park JW YC-1: A potential anticancer drug targeting hypoxia-inducible factor 1 J Natl Cancer Inst 2003 95 7 516-525 12671019
41. Zou MH Kirkpatrick SS Davis BJ Nelson JS Wiles WG Schlattner U Neumann D Brownlee M Freeman MB Goldman MH Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species. J Biol Chem 2004 279 42 43940-43951 10.1074/jbc.M404421200 15265871
42. Jiang M Wang B Wang C He B Fan H Guo TB Shao Q Gao L Liu Y Inhibition of hypoxia-inducible factor-1alpha and endothelial progenitor cell differentiation by adenoviral transfer of small interfering RNA in vitro J Vasc Res 2006 43 6 511-521 10.1159/000095964 17008771
43. Pore N Liu S Shu HK Li B Haas-Kogan D Stokoe D Milanini-Mongiat J Pages G O'Rourke DM Bernhard E Maity A Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism Mol Biol Cell 2004 15 11 4841-4853 524732 15342781 10.1091/mbc.E04-05-0374
44. Zhang X Kon T Wang H Li F Huang Q Rabbani ZN Kirkpatrick JP Vujaskovic Z Dewhirst MW Li CY Enhancement of hypoxia-induced tumor cell death in vitro and radiation therapy in vivo by use of small interfering RNA targeted to hypoxia-inducible factor-1alpha Cancer Res 2004 64 22 8139-8142 10.1158/0008-5472.CAN-03-2301 15548675
45. Hurst RE Kamat CD Kyker KD Green DE Ihnat MA A novel multidrug resistance phenotype of bladder tumor cells grown on Matrigel or SIS gel Cancer Lett 2005 217 2 171-180 10.1016/j.canlet.2004.07.043 15617834
46. Timms RM Kvale PA Anthonisen NR Boylen CT Cugell DW Petty TL Williams GW Selection of patients with chronic obstructive pulmonary disease for long-term oxygen therapy. JAMA UNITED STATES 1981 245 24 2514-2515 10.1001/jama.245.24.2514 7014957
47. Young IH Woolcock AJ Arterial blood gas tension changes at the start of exercise in chronic obstructive pulmonary disease. Am Rev Respir Dis UNITED STATES 1979 119 2 213-221 434594
48. Shepard JW Gas exchange and hemodynamics during sleep. Med Clin North Am UNITED STATES 1985 69 6 1243-1264 3906302
49. Strickland RA Hill TR Zaloga GP Bedside analysis of arterial blood gases and electrolytes during and after cardiac surgery J Clin Anesth 1989 1 4 248-252 10.1016/0952-8180(89)90021-4 2627398
50. Gleadle JM Ratcliffe PJ Induction of hypoxia-inducible factor-1, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: Evidence against a regulatory role for Src kinase Blood 1997 89 2 503-509 9002952
51. Bruick RK Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia Proc Natl Acad Sci U S A 2000 97 16 9082-9087 16825 10922063 10.1073/pnas.97.16.9082
52. Kietzmann T Roth U Jungermann K Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes Blood 1999 94 12 4177-4185 10590062
53. Melillo G Taylor LS Brooks A Musso T Cox GW Varesio L Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine J Biol Chem 1997 272 18 12236-12243 10.1074/ jbc.272.18.12236 9115299
54. Liu Y Cox SR Morita T Kourembanas S Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer Circ Res 1995 77 3 638-643 7641334
55. Kietzmann T Gorlach A Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression. Semin Cell Dev Biol 2005 16 4-5 474-486 10.1016/j.semcdb.2005.03.010 15905109
56. Kim HL Yeo EJ Chun YS Park JW A domain responsible for HIF-1alpha degradation by YC-1, a novel anticancer agent. Int J Oncol 2006 29 1 255-260 16773207
57. Smith AR Shenvi SV Widlansky M Suh JH Hagen TM Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress Curr Med Chem 2004 11 9 1135-1146 15134511
58. Naseem KM The role of nitric oxide in cardiovascular diseases Mol Aspects Med 2005 26 1-2 33-65 10.1016/j.mam.2004.09.003 15722114
59. Dvorak HF Brown LF Detmar M Dvorak AM Vascular permeability factor/ vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995 146 5 1029-1039 7538264
60. Detmar M Brown LF Schon MP Elicker BM Velasco P Richard L Fukumura D Monsky W Claffey KP Jain RK Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 1998 111 1 1-6 10.1046/j.1523-1747.1998.00262.x 9665379
61. Vaughan DE PAI-1 and atherothrombosis. J Thromb Haemost 2005 3 8 1879-1883 10.1111/j.1538-7836.2005.01420.x 16102055
62. Kubasiak LA Hernandez OM Bishopric NH Webster KA Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proc Natl Acad Sci U S A 2002 99 20 12825-12830 130544 12226479 10.1073/ pnas.202474099
63. Raval RR Lau KW Tran MG Sowter HM Mandriota SJ Li JL Pugh CW Maxwell PH Harris AL Ratcliffe PJ Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma Mol Cell Biol 2005 25 13 5675-5686 1157001 15964822 10.1128/ MCB.25.13.5675-5686.2005
64. Sowter HM Raval RR Moore JW Ratcliffe PJ Harris AL Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia Cancer Res 2003 63 19 6130-6134 14559790
65. Wang V Davis DA Haque M Huang LE Yarchoan R Differential gene up-regulation by hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha in HEK293T cells Cancer Res 2005 65 8 3299-3306 15833863
66. Sowter HM Ratcliffe PJ Watson P Greenberg AH Harris AL HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors Cancer Res 2001 61 18 6669-6673 11559532
67. Calvani M Rapisarda A Uranchimeg B Shoemaker RH Melillo G Hypoxic induction of a HIF-1{alpha}- dependent bFGF autocrine loop drives angiogenesis in human endothelial cells Blood 2005 16304044
68. Carroll VA Ashcroft M Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: Implications for targeting the HIF pathway. Cancer Res 2006 66 12 6264-6270 10.1158/0008-5472.CAN-05-2519 16778202
69. Kelley EE Hock T Khoo NK Richardson GR Johnson KK Powell PC Giles GI Agarwal A Lancaster JRJ Tarpey MM Moderate hypoxia induces xanthine oxidoreductase activity in arterial endothelial cells. Free Radic Biol Med 2006 40 6 952-959 10.1016/j.freeradbiomed.2005.11.008 16540390
70. Radi R Nitric oxide, oxidants, and protein tyrosine nitration Proc Natl Acad Sci U S A 2004 101 12 4003-4008 384685 15020765 10.1073/ pnas.0307446101
71. Appelhoff RJ Tian YM Raval RR Turley H Harris AL Pugh CW Ratcliffe PJ Gleadle JM Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor J Biol Chem 2004 279 37 38458-38465 10.1074/jbc.M406026200 15247232
72. Callapina M Zhou J Schmid T Kohl R Brune B NO restores HIF-1alpha hydroxylation during hypoxia: Role of reactive oxygen species Free Radic Biol Med 2005 39 7 925-936 10.1016/j.freeradbiomed.2005.05.009 16140212